More:    MJNA HOME        CANNABIS NEWS        SHOP        CONTACT 

  • Dashboard
  • Reports & Disclosure
  • Financial Results
  • Shareholder
    • Shareholder Information
    • Shareholder Rewards
  • News
    • Media Coverage
    • Press Releases
  • Follow
  • Follow
  • Follow
  • Follow
  • Follow
  • Follow
  • Dashboard
  • Reports & Disclosure
  • Financial Results
  • Shareholder
    • Shareholder Information
    • Shareholder Rewards
  • News
    • Media Coverage
    • Press Releases
MJBiz Daily, Pot Stock News, and The San Diego Union Tribune Included Coverage of MJNA This Week

MJBiz Daily, Pot Stock News, and The San Diego Union Tribune Included Coverage of MJNA This Week

by adminAdrianRamirez | Jan 24, 2019 | HempMeds, Media Coverage, Real Scientific Hemp Oil

Medical cannabis in Brazil, the U.S. hemp industry, and investing in cannabis lead Medical Marijuana, Inc. headlines this past week. The Medical Marijuana, Inc. family of companies were in the news again this week. Here are our highlights from last week’s media...
Medical Marijuana, Inc. CEO and Subsidiary Kannaway® CEO Invited to Speak at SUCCESS Partners® CBD Symposium in Anaheim, California

Medical Marijuana, Inc. CEO and Subsidiary Kannaway® CEO Invited to Speak at SUCCESS Partners® CBD Symposium in Anaheim, California

by adminAdrianRamirez | Jan 23, 2019 | Kannaway, Press Releases

SAN DIEGO, Jan. 23, 2019 — Medical Marijuana, Inc. (OTC:MJNA), the first-ever publicly traded cannabis company in the United States, announced today that Medical Marijuana, Inc. CEO Dr. Stuart Titus and Kannaway® CEO Blake Schroeder have been invited to speak at...
PBS NewsHour Features Medical Marijuana, Inc. CEO Discussing Hemp’s Future in the U.S. and the Government Shutdown’s Effect On It

PBS NewsHour Features Medical Marijuana, Inc. CEO Discussing Hemp’s Future in the U.S. and the Government Shutdown’s Effect On It

by adminAdrianRamirez | Jan 22, 2019 | Press Releases

SAN DIEGO, Jan. 22, 2019 — Medical Marijuana, Inc. (OTC:MJNA), the first publicly traded cannabis company in the United States, today announced that it has garnered news coverage in national news publication PBS NewsHour. A Jan. 8, 2019, article on the 2018 Farm...
PBS NewsHour Leads Medical Marijuana, Inc. Headlines This Week

PBS NewsHour Leads Medical Marijuana, Inc. Headlines This Week

by adminAdrianRamirez | Jan 18, 2019 | Axim Biotechnologies, Cannabis Beauty Defined, Kannalife Sciences, Media Coverage

Hemp farmers affected by government shutdown, a look at global cannabis legalization, and CBD for skin care among recent Medical Marijuana, Inc. news. The future of hemp cultivation in America, shifting cannabis policy in Mexico, and CBD beauty products are trending...
Medical Marijuana, Inc. Subsidiary HempMeds® Launches Real Scientific Hemp Oil™ Maximum Strength

Medical Marijuana, Inc. Subsidiary HempMeds® Launches Real Scientific Hemp Oil™ Maximum Strength

by adminAdrianRamirez | Jan 17, 2019 | HempMeds, Press Releases

SAN DIEGO, Jan. 16, 2019 — Medical Marijuana, Inc. (OTC: MJNA), the first-ever publicly traded cannabis company in the United States, subsidiary HempMeds® announced today the release of its newest cannabidiol (CBD) product Real Scientific Hemp Oil™ (RSHO™)...
« Older Entries
Next Entries »

Recent Posts

  • Medical Marijuana, Inc. Appoints New CEO; Highlights Renewed Focus on Profitability, Further Expansion
  • Medical Marijuana, Inc. Subsidiary HempMeds® Brasil Launches Two New Full Spectrum Concentrations in Brazil With Competitive Price Point
  • Medical Marijuana, Inc. Subsidiary Kannaway Expands Leadership Team With Appointment of Industry Veterans to Roles of Executive Vice President and Vice President of Information Technology
  • Medical Marijuana, Inc. Subsidiary HempMeds® Brasil Celebrates Major Features Across Several Marquee Brazilian Press Outlets
  • Medical Marijuana, Inc. Subsidiary HempMeds® Mexico Participates in Research Finding Promising Therapeutic Benefits of CBD in Parkinson’s Disease Treatment

Recent Comments

No comments to show.

Home     Company    Education     Careers     Shop

This article may contain certain forward-looking statements and information, as defined within the meaning of Section 27A of the Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934, and is subject to the Safe Harbor created by those sections. This material contains statements about expected future events and/or financial results that are forward-looking in nature and subject to risks and uncertainties. Such forward-looking statements by definition involve risks, uncertainties.

Food and Drug Administration (FDA) Disclosure

These statements have not been evaluated by the Food and Drug Administration. This product is not intended to diagnose, treat, cure, or prevent any disease.

Leaving Our Website Disclaimer: If we have a research link to a website where we sell products or have product information you are now leaving the medicalmarijuanainc.com website. Links to any informational websites are provided solely as a service to our users.

The link provides additional information that may be useful or interesting and has no aliation to the promotion, sale and distribution of Medical Marijuana Inc. products. The link does not constitute an endorsement of these organizations by Medical Marijuana Inc. and none should be inferred. Please view our full Terms Of Use Agreement for more information and the terms and conditions governing your use of this site.

* Cannabidiol (CBD) is a naturally-occurring constituent of the industrial hemp plant.

Medical Marijuana Inc. does not sell or distribute any products that are in violation of the United States Controlled Substances Act (US.CSA). The company does grow, sell and distribute hemp based products.

© 2021 Medical Marijuana, Inc. All Rights Reserved.